Visionix USA announces US launch of VX 610 fundus camera

News
Article

The device features cross-polarized light technology, allowing for image clarity without the need for pupil dilation.

VX 610 fundus camera with retinal images Image credit: Visionix USA

Image credit: Visionix USA

Visionix USA has announced the launch of its VX 610 non-mydriatic automated fundus camera.1 The device features auto alignment, auto focus, and auto capture functions for retinal imaging, according to a news release.

“Our goal is to continuously advance eye care technology, enhance the patient experience, and improve the productivity of eye care professionals,” said Peter Wyles, CEO of Visionix USA, in a statement. “The VX 610 fundus camera demonstrates this commitment with its clear images, compact design, and automated capture features, ensuring precision and efficiency in screening and diagnostics.”

The VX 610 utilizes cross-polarized light technology, which allows for image clarity without the need for pupil dilation.1 Images filters include vascular, choroidal, nerve fibre, and red free, in addition to cup-to-disc ratio for glaucoma screening.2 The device also has a 45-degree field of view and 90-degree mosaic function, with a retinal resolution of 14 microns. In addition to a secured, cloud-based storage ability and automatic database backup, VX 610 also includes a fundus adapter to transfer images to a local PC.2

The device will be featured at Vision Expo West, being held from September 18-21 at the Venetian Expo in Las Vegas, Nevada. At Visionix’s booth #F10065, attendees will be able to experience a live demo of VX 610, in addition to viewing the company’s Optovue OCTs and OCTAs and Briot/Weco lens finishing platforms.1

References:
  1. Visionix unveils the VX 610 automated fundus camera. News release. Visionix USA. August 21, 2024. Accessed August 22, 2024.
  2. Visionix VX 610. Visionix USA. Accessed August 22, 2024. https://www.visionix.com/us/product/vx-610-automated-fundus-camera/
Recent Videos
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
© 2024 MJH Life Sciences

All rights reserved.